Immunology and Microbiology
Multiple Sclerosis
100%
Clinically Isolated Syndrome
44%
Experimental Autoimmune Encephalomyelitis
38%
Blood Brain Barrier
34%
Immunology
32%
Prevalence
25%
Neuromyelitis Optica
25%
Central Nervous System
23%
Rabies Virus
20%
Tumor Necrosis Factor Alpha
19%
Spinal Cord
17%
Myelin Oligodendrocyte Glycoprotein
15%
B Cell
14%
Immunity
14%
Cell Invasion
12%
Immunoglobulin Blood Level
11%
Immunoglobulin G
11%
Regulatory T Cell
10%
Autoimmunity
10%
Myelin
10%
Epstein Barr Virus
10%
Epitope
10%
Intercellular Adhesion Molecule 1
9%
Aquaporin 4 Antibody
9%
T Cell
8%
Magnetic Resonance Imaging
8%
TBX21
8%
Pylorus
8%
Monoclonal Antibody
8%
Cell Culture
8%
Beta Interferon
8%
Plant Cell
8%
Relapsing Remitting Multiple Sclerosis
8%
Immunomodulation
8%
Inflammation Response
8%
Cell Suspension
8%
Suspension Cell Culture
8%
Immunoglobulin G3
8%
Genome-Wide Association Study
8%
Upregulation
8%
Insulin Release
8%
Virus Antibody
8%
Allele
8%
Knockout Mouse
8%
Autologous Stem Cell Transplantation
8%
Leukocyte
8%
Helicobacter Pylori
8%
Oxidative Stress
8%
Mouse Model
8%
Human Leukocyte Antigen
8%
Neuroscience
Multiple Sclerosis
90%
Demyelinating Disease
34%
T Cell
17%
Experimental Autoimmune Encephalomyelitis
16%
Central Nervous System
16%
Blood Brain Barrier
16%
Fingolimod
16%
Myelin Oligodendrocyte Glycoprotein
15%
Natalizumab
14%
Cladribine
14%
Immunoglobulin G
11%
Genome-Wide Association Study
10%
Beta Interferon
10%
Tumor Necrosis Factor Alpha
9%
Arginine
8%
Relapsing Remitting Multiple Sclerosis
8%
Tryptophan
8%
Interferon
8%
Oxidative Stress
8%
Glutamate Ammonia Ligase
8%
Aquaporin 4 Antibody
8%
Epitope
8%
Leukocyte
8%
Helicobacter
8%
Stem Cell
8%
Neuromyelitis Optica
8%
Immunoglobulin G3
8%
Longitudinal Study
8%
Lymphocyte
8%
B Cell
7%
Indoleamine 2,3 Dioxygenase
5%
Messenger RNA
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
85%
Cladribine
19%
Disease
19%
Demyelinating Disease
18%
Experimental Autoimmune Encephalomyelitis
16%
Fingolimod
13%
Natalizumab
11%
Therapeutic Effect
9%
Beta Interferon
9%
Mouse Model
8%
Retinol
8%
Controlled Clinical Trial
8%
Fabry Disease
8%
Knockout Mouse
8%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
8%
Expanded Disability Status Scale
8%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
8%
N,n Dimethylacetamide
8%
Myelooptic Neuropathy
8%
Interferon
8%
Pandemic
8%
Tablet
8%
Prevalence
8%
Biological Marker
8%
Immunomodulation
8%
Vitamin D
8%
Blood-Brain Barrier
8%